World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $690.55bn | 72.14 | 0.62% |
NOVO BNovo Nordisk A/S | DKK3.86tn | 45.6 | 1.09% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $356.43bn | 16.21 | 3.22% |
MRKMerck & Co | $318.60bn | 91.93 | 2.35% |
ABBVAbbvie | $294.65bn | 36.63 | 3.56% |
AZNAstraZeneca | £169.69bn | 39.72 | 2.14% |
ROGRoche Holding AG | CH₣177.07bn | 12.34 | 4.32% |
RORoche Holding AG | CH₣177.07bn | 13.23 | 4.03% |
NOVNNovartis AG | CH₣174.83bn | 17.25 | 4.17% |
PFEPfizer | $147.23bn | 8.12 | 6.31% |
AMGNAmgen | $144.25bn | 21.03 | 3.17% |
SANSanofi SA | €108.73bn | 16.44 | 4.33% |
CELG RTBristol-Myers Squibb Co | $99.17bn | 0.02 | 4000% |
BMYBristol-Myers Squibb Co | $99.17bn | 13.05 | 4.66% |
CSLCSL | AU$130.19bn | 32.67 | 1.48% |
GILDGilead Sciences | $83.25bn | 11.52 | 4.49% |
GSKGSK | £66.28bn | 11.4 | 3.63% |
MCKMcKesson | $68.97bn | 23.32 | 0.43% |
MRKMerck KGaA | €63.48bn | 19.03 | 1.51% |